BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 16127744)

  • 21. Persistence of gene expression changes in noninflamed and inflamed colonic mucosa in ulcerative colitis and their presence in colonic carcinoma.
    Toiyama Y; Mizoguchi A; Kimura K; Araki T; Yoshiyama S; Sakaguchi K; Miki C; Kusunoki M
    World J Gastroenterol; 2005 Sep; 11(33):5151-5. PubMed ID: 16127744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in ulcerative colitis.
    Wang YD; Yan PY
    World J Gastroenterol; 2006 Oct; 12(37):6050-3. PubMed ID: 17009408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Downregulation of serotonin reuptake transporter gene expression in healing colonic mucosa in presence of remaining low-grade inflammation in ulcerative colitis.
    Tada Y; Ishihara S; Kawashima K; Fukuba N; Sonoyama H; Kusunoki R; Oka A; Mishima Y; Oshima N; Moriyama I; Yuki T; Ishikawa N; Araki A; Harada Y; Maruyama R; Kinoshita Y
    J Gastroenterol Hepatol; 2016 Aug; 31(8):1443-52. PubMed ID: 26676714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA exhibit altered expression in the inflamed colonic mucosa of ulcerative colitis patients.
    Valmiki S; Ahuja V; Paul J
    World J Gastroenterol; 2017 Aug; 23(29):5324-5332. PubMed ID: 28839432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of hepatocyte growth factor and c-met in ulcerative colitis.
    Kitamura S; Kondo S; Shinomura Y; Isozaki K; Kanayama S; Higashimoto Y; Minami T; Kiyohara T; Yasunaga Y; Ishikawa H; Ohtani T; Ishiguro S; Matsuzawa Y
    Inflamm Res; 2000 Jul; 49(7):320-4. PubMed ID: 10959552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA methylation of colon mucosa in ulcerative colitis patients: correlation with inflammatory status.
    Saito S; Kato J; Hiraoka S; Horii J; Suzuki H; Higashi R; Kaji E; Kondo Y; Yamamoto K
    Inflamm Bowel Dis; 2011 Sep; 17(9):1955-65. PubMed ID: 21830274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cortisone in ulcerative colitis; final report on a therapeutic trial.
    TRUELOVE SC; WITTS LJ
    Br Med J; 1955 Oct; 2(4947):1041-8. PubMed ID: 13260656
    [No Abstract]   [Full Text] [Related]  

  • 28. Distinct gene expression of osteopontin in patients with ulcerative colitis.
    Masuda H; Takahashi Y; Asai S; Takayama T
    J Surg Res; 2003 May; 111(1):85-90. PubMed ID: 12842452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A vasoactive intestinal peptide receptor analog alters the expression of homeobox genes.
    Steingart RA; Heldenberg E; Pinhasov A; Brenneman DE; Fridkin M; Gozes I
    Life Sci; 2002 Oct; 71(21):2543-52. PubMed ID: 12270759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Animal models of inflammatory bowel disease.
    Hibi T; Ogata H; Sakuraba A
    J Gastroenterol; 2002; 37(6):409-17. PubMed ID: 12108674
    [No Abstract]   [Full Text] [Related]  

  • 31. Identification of candidate genes in ulcerative colitis and Crohn's disease using cDNA array technology.
    Uthoff SM; Eichenberger MR; Lewis RK; Fox MP; Hamilton CJ; McAuliffe TL; Grimes HL; Galandiuk S
    Int J Oncol; 2001 Oct; 19(4):803-10. PubMed ID: 11562759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Homeobox genes in normal and malignant cells.
    Cillo C; Cantile M; Faiella A; Boncinelli E
    J Cell Physiol; 2001 Aug; 188(2):161-9. PubMed ID: 11424082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epithelial proliferation and ras p21 oncoprotein expression in rectal mucosa of patients with ulcerative colitis.
    Ierardi E; Principi M; Francavilla R; Passaro S; Noviello F; Burattini O; Francavilla A
    Dig Dis Sci; 2001 May; 46(5):1083-7. PubMed ID: 11341653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ulcerative colitis and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidate genes.
    Lawrance IC; Fiocchi C; Chakravarti S
    Hum Mol Genet; 2001 Mar; 10(5):445-56. PubMed ID: 11181568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of mucosal gene expression in inflammatory bowel disease by parallel oligonucleotide arrays.
    Dieckgraefe BK; Stenson WF; Korzenik JR; Swanson PE; Harrington CA
    Physiol Genomics; 2000 Nov; 4(1):1-11. PubMed ID: 11074008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deregulated expression of homeobox-containing genes, HOXB6, B8, C8, C9, and Cdx-1, in human colon cancer cell lines.
    Vider BZ; Zimber A; Chastre E; Gespach C; Halperin M; Mashiah P; Yaniv A; Gazit A
    Biochem Biophys Res Commun; 2000 Jun; 272(2):513-8. PubMed ID: 10833444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ca(2+)-dependent gene expression mediated by MEF2 transcription factors.
    Blaeser F; Ho N; Prywes R; Chatila TA
    J Biol Chem; 2000 Jan; 275(1):197-209. PubMed ID: 10617605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD28-mediated regulation of the c-jun promoter involves the MEF2 transcription factor in Jurkat T cells.
    Shin HM; Han TH
    Mol Immunol; 1999 Feb; 36(3):197-203. PubMed ID: 10403485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Homeobox genes and cancer.
    Cillo C; Faiella A; Cantile M; Boncinelli E
    Exp Cell Res; 1999 Apr; 248(1):1-9. PubMed ID: 10094807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins.
    Black BL; Olson EN
    Annu Rev Cell Dev Biol; 1998; 14():167-96. PubMed ID: 9891782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.